[Current approaches to the treatment of patients with systemic scleroderma].
Principles are highlighted of modern therapy of systemic scleroderma involving prescription of basis agents, such as, in the first place, thiol compounds as well as drugs affecting certain links of the disease pathogenesis, in particular, antifibrotic, vasodilative, anti-inflammatory ones. Methods are presented of therapy of systemic scleroderma with unithiol and superelectrophoresis of unithiol with dimexide, developed by the author. Syndrome therapy of the disease is characterized taking account of damage to certain organs and systems.
Huĭda
P P
PP
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage; D004121:Dimethyl Sulfoxide / Q000008:administration & dosage / Q000009:adverse effects; D004359:Drug Therapy, Combination; D006801:Humans; D007478:Iontophoresis; D012595:Scleroderma, Systemic / Q000188:drug therapy*; D013997:Time Factors; D014494:Unithiol / Q000008:administration & dosage / Q000009:adverse effects; D014665:Vasodilator Agents / Q000008:administration & dosage
D000305:Adrenal Cortex Hormones; D000891:Anti-Infective Agents, Local; D014665:Vasodilator Agents; D014494:Unithiol; D004121:Dimethyl Sulfoxide
Suchasni pidkhody do likuvannia khvorykh na systemnu sklerodermiiu.